Protabit
Pasadena
About Protabit
Protabit engineers proteins for industrial, agricultural, and healthcare applications. Its platform technology is being developed via a strategic partnership with the Monsanto Company and the California Institute of Technology. Protabit’s protein engineering approach combines computational modeling with high-throughput screening and directed evolution to expand the diversity of protein sequences that can be explored to produce novel proteins.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Last round: Grant (Jun 2022)
- Website: protabit.com
- Phone: +1 626-844-7348
Industries & Categories
Biotechnology, Genetics, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/protabit-21 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.